Pharma underutilises avenues to attract, retain trial patients; advocacy influence rising, delegates at Arena International say

15 Jun 2018

Pharma can better attract patients to clinical trials through working with patient advocacy groups to generate feasible trial designs and offering to offset trial costs, said delegates at Arena International’s Outsourcing in Clinical Trials UK and Ireland 2018.

Speakers also touched on the need for trial recruitment and retention improvements, with a focus on the use of social media for recruitment and consistent communication between patients and trial sites -- during and after trials -- to ensure patient retention and continued involvement in future studies.

Delegates included those from small pharma, big pharma, specialty CROs, trial vendors and consulting firms, with the ultimate conclusion being that there are multiple underutilised methods to engage and retain patients.

Public buzz on an upcoming trial can be created by publishing a series of short articles or advertisements on online portals; these can include blogs, online magazines, patient advocacy and charity websites, said Tanja Ouimet, director of Clinical Development, Pharma Leads. In addition, publicising on Twitter, Facebook and YouTube, amongst social media tools, can also boost recruitment numbers, she and patient advocate Trishna Bharadia said.

Already a subscriber? Login to read the full article.

 
1 Start 2 Complete